DE60022742D1 - Salz des (2r,3r,4r)-3,4-dihydroxy-2-hydroxmethylpyrrolidins - Google Patents

Salz des (2r,3r,4r)-3,4-dihydroxy-2-hydroxmethylpyrrolidins

Info

Publication number
DE60022742D1
DE60022742D1 DE60022742T DE60022742T DE60022742D1 DE 60022742 D1 DE60022742 D1 DE 60022742D1 DE 60022742 T DE60022742 T DE 60022742T DE 60022742 T DE60022742 T DE 60022742T DE 60022742 D1 DE60022742 D1 DE 60022742D1
Authority
DE
Germany
Prior art keywords
hydroxymethylpyrrolidine
dihydroxy
salt
tartrate
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60022742T
Other languages
English (en)
Inventor
Ulrich Jessen
Petra Christine Lugstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of DE60022742D1 publication Critical patent/DE60022742D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DE60022742T 1999-03-15 2000-03-13 Salz des (2r,3r,4r)-3,4-dihydroxy-2-hydroxmethylpyrrolidins Expired - Lifetime DE60022742D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900363 1999-03-15
PCT/DK2000/000104 WO2000055131A1 (en) 1999-03-15 2000-03-13 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine

Publications (1)

Publication Number Publication Date
DE60022742D1 true DE60022742D1 (de) 2006-02-02

Family

ID=8092679

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60022742T Expired - Lifetime DE60022742D1 (de) 1999-03-15 2000-03-13 Salz des (2r,3r,4r)-3,4-dihydroxy-2-hydroxmethylpyrrolidins

Country Status (6)

Country Link
EP (1) EP1163217B1 (de)
JP (1) JP2002539194A (de)
AT (1) ATE304998T1 (de)
AU (1) AU3147800A (de)
DE (1) DE60022742D1 (de)
WO (1) WO2000055131A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070249623A1 (en) * 2004-06-30 2007-10-25 Eli Lilly And Company Patent Division 1-(Indole-6-Carbonyl-D-Phenylglycinyl)-4-(1-Methylpiperidin-4-Yl)Piperazine D-Tartrate
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1040827A3 (de) * 1995-09-08 2000-10-11 Novo Nordisk A/S Verwendung von 3,4-dihydroxy-2-hydroxymethylpyrrolidin zur behandlung von diabetes

Also Published As

Publication number Publication date
AU3147800A (en) 2000-10-04
EP1163217B1 (de) 2005-09-21
WO2000055131A1 (en) 2000-09-21
JP2002539194A (ja) 2002-11-19
ATE304998T1 (de) 2005-10-15
EP1163217A1 (de) 2001-12-19

Similar Documents

Publication Publication Date Title
MXPA02010801A (es) Agentes diagnosticos, de representacion y terapeuticos cationicos asociados con sitios vasculares activados.
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
YU40701A (sh) Piperidini kao modulatori ccr5
HRP20031003A2 (en) 4'-substituted nukleosides
GB0222495D0 (en) Compounds
MXPA05002814A (es) Formulacion para agentes lipofilicos.
MY143795A (en) Tetrahydropyridoindole derivatives
PL375621A1 (en) Pharmaceutical compositions comprising flavonoids and menthol
TW200611695A (en) Pyrrolopyridine derivatives
GB0111186D0 (en) Novel compounds
TW200505875A (en) Novel compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200716204A (en) Pharmaceutical composition
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
MXPA03005601A (es) Nuevos compuestos y composiciones como inhibidores de catepsina.
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SI1622939T1 (sl) Akrivne variante il-18 vezavnega proteina in medicinske uporabe le-tega
MXPA03010766A (es) Nuevos compuestos y composiciones como inhibicores de las catepsinas.
GB0320320D0 (en) Novel compounds
GR20020100478A (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
BR0009211A (pt) Derivados de resorcinol
UY26426A1 (es) Nuevos compuestos
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados

Legal Events

Date Code Title Description
8332 No legal effect for de